Rituximab in Patients With Relapsed or Refractory TTP-HUS

Clinical trial NCT00531089 · UNKNOWN

Trial details

NCT number: NCT00531089
Sponsor: Hamilton Health Sciences Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombotic Thrombocytopenic Purpura Hemolytic Uremic Syndrome

Start date: 2007-12-01
Primary completion: 2011-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.